Category: Pharmaceuticals

Pharmaceuticals

Avadel Awaits FDA Decision on Once-Nightly Sodium Oxybate for Narcolepsy; Launch Prep Progressing

Avadel Pharmaceuticals plc recently provided a corporate update and announced its financial results for the third quarter ended September 30, 2021.

Pharmaceuticals

Study: Melatonin Safe Sleep Aid for Adults with Metabolic Diseases

Melatonin may be a safe sleep aid for people with metabolic diseases and for healthy adults, and data suggest a beneficial glucose effect, according to findings published in Clinical Endocrinology.

Pharmaceuticals

Idorsia ‘Progressing Very Well’ with Prep for Anticipated Launch of Insomnia Drug Candidate

Allschwil, Switzerland-based Idorsia Ltd recently announced its financial results for the first half of 2021, at which time its drug daridorexant for the treatment of insomnia under review with United States FDA, EMA, and Swissmedic.

Prescription Drugs

Two Poster Presentations Include New Post-Hoc Analyses That Highlight Clinical Effectiveness of WAKIX

"The analyses include both a traditional approach to presenting efficacy data, as well as one that underscores the clinical relevance of the findings, using [number needed to treat] and effect sizes to capture overall clinical benefit."

Over-the-Counter Treatments

Is Vaping Melatonin Safe?

Discover Magazine investigates how inhaling melatonin came to become a new trend and if the practice could damage the lungs.

Emerging Compounds

Avadel Presents Data from Phase 3 Trial Supporting Clinical Benefit of FT218 in Patients with Narcolepsy

“The new data analyses showing that FT218 improved excessive daytime sleepiness in patients with narcolepsy, both with and without cataplexy, regardless of stimulant use, are important for this patient population."